DaShenLin Pharmaceutical Group Co., Ltd. (SHA:603233)
China
· Delayed Price · Currency is CNY 17.72
-0.69 (-3.75%)
May 14, 2025, 11:29 AM CST
SHA:603233 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | May '25 May 13, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 20,738 | 17,151 | 28,359 | 37,585 | 33,307 | 51,603 | Upgrade
|
| Market Cap Growth | -23.10% | -39.52% | -24.55% | 12.85% | -35.46% | 89.92% | Upgrade
|
| Enterprise Value | 22,108 | 20,006 | 31,251 | 40,044 | 35,732 | 49,307 | Upgrade
|
| Last Close Price | 18.21 | 15.06 | 23.91 | 31.08 | 27.14 | 41.58 | Upgrade
|
| PE Ratio | 21.12 | 18.75 | 24.31 | 36.29 | 42.10 | 48.58 | Upgrade
|
| Forward PE | 19.77 | 16.44 | 23.76 | 31.37 | 28.06 | 49.98 | Upgrade
|
| PS Ratio | 0.78 | 0.65 | 1.16 | 1.77 | 1.99 | 3.54 | Upgrade
|
| PB Ratio | 2.40 | 2.11 | 3.58 | 5.48 | 5.61 | 9.26 | Upgrade
|
| P/TBV Ratio | 11.01 | 12.20 | 14.61 | 11.71 | 11.90 | 14.49 | Upgrade
|
| P/FCF Ratio | 8.68 | 10.52 | 20.59 | 13.81 | 128.08 | 44.42 | Upgrade
|
| P/OCF Ratio | 5.69 | 5.52 | 8.94 | 10.01 | 21.42 | 26.41 | Upgrade
|
| PEG Ratio | - | 1.92 | 1.92 | 1.92 | 1.92 | 1.92 | Upgrade
|
| EV/Sales Ratio | 0.83 | 0.76 | 1.27 | 1.89 | 2.13 | 3.38 | Upgrade
|
| EV/EBITDA Ratio | 6.85 | 6.39 | 9.63 | 22.15 | 27.36 | 32.16 | Upgrade
|
| EV/EBIT Ratio | 13.73 | 12.93 | 17.40 | 25.18 | 32.45 | 36.19 | Upgrade
|
| EV/FCF Ratio | 9.25 | 12.27 | 22.69 | 14.71 | 137.41 | 42.45 | Upgrade
|
| Debt / Equity Ratio | 0.79 | 0.95 | 0.82 | 0.86 | 0.89 | 0.25 | Upgrade
|
| Debt / EBITDA Ratio | 2.12 | 2.47 | 2.01 | 2.06 | 2.34 | 0.91 | Upgrade
|
| Debt / FCF Ratio | 2.86 | 4.75 | 4.73 | 2.18 | 20.29 | 1.21 | Upgrade
|
| Asset Turnover | 1.02 | 1.05 | 1.09 | 1.11 | 1.13 | 1.39 | Upgrade
|
| Inventory Turnover | 4.16 | 4.19 | 3.92 | 3.53 | 3.29 | 3.80 | Upgrade
|
| Quick Ratio | 0.62 | 0.58 | 0.54 | 0.62 | 0.55 | 0.93 | Upgrade
|
| Current Ratio | 0.97 | 0.92 | 0.94 | 1.10 | 1.10 | 1.52 | Upgrade
|
| Return on Equity (ROE) | 11.98% | 12.20% | 16.63% | 16.86% | 13.98% | 21.87% | Upgrade
|
| Return on Assets (ROA) | 3.86% | 3.83% | 4.99% | 5.21% | 4.64% | 8.11% | Upgrade
|
| Return on Capital (ROIC) | 6.55% | 6.38% | 8.24% | 8.28% | 7.57% | 14.64% | Upgrade
|
| Return on Capital Employed (ROCE) | 12.30% | 12.20% | 14.20% | 14.30% | 10.80% | 19.90% | Upgrade
|
| Earnings Yield | 4.71% | 5.33% | 4.11% | 2.76% | 2.38% | 2.06% | Upgrade
|
| FCF Yield | 11.52% | 9.51% | 4.86% | 7.24% | 0.78% | 2.25% | Upgrade
|
| Dividend Yield | 3.37% | 4.12% | 1.30% | 1.61% | 1.28% | 1.11% | Upgrade
|
| Payout Ratio | 77.87% | 82.34% | 51.82% | 40.58% | 67.53% | 31.38% | Upgrade
|
| Buyback Yield / Dilution | -0.15% | 0.28% | 0.50% | -0.69% | 0.24% | -2.65% | Upgrade
|
| Total Shareholder Return | 3.22% | 4.40% | 1.79% | 0.92% | 1.52% | -1.53% | Upgrade
|
Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.